HISERPIA Drug Patent Profile
✉ Email this page to a colleague
When do Hiserpia patents expire, and when can generic versions of Hiserpia launch?
Hiserpia is a drug marketed by Bowman Pharms and is included in one NDA.
The generic ingredient in HISERPIA is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Summary for HISERPIA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 1,214 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HISERPIA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HISERPIA
US Patents and Regulatory Information for HISERPIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bowman Pharms | HISERPIA | reserpine | TABLET;ORAL | 009631-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bowman Pharms | HISERPIA | reserpine | TABLET;ORAL | 009631-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |